passage bio stock forecast
PASG will reduce its workforce by approximately 13 and prioritize its RD programs in partnership with the University of Pennsylvanias Gene Therapy Program. PASG stock quote history news and other vital information to help you with your stock trading and investing.
Passage Bio Inc NASDAQ.
. Ad Horizon Is A Leading High-Growth Biopharma Company. In other news major shareholder Orbimed Advisors Llc acquired 369100 shares of Passage Bio stock in a transaction on Thursday January 20th. On average they anticipate Passage Bios.
Down from US2738 the current price target is an average from 7 analysts. Their forecasts range from 600 to 3400. The stock was bought at an.
Related
The stock options have an exercise price of 261 per share which is equal to the closing price of Passage Bios common stock on April 18 2022 the grant date of the option. Passage Bio has not formally confirmed its next earnings publication date. PASG a clinical-stage genetic medicines company focused on developing transformative.
Ad Horizon Is A Leading High-Growth Biopharma Company. If you are looking for stocks with good return Passage Bio Inc. Stock is down 76 over the past year.
Learn More About Our Differentiated RD Strategy. Is a clinical stage genetic medicines company. Ad Magnify Your Bull Bear Exposure to Biotech with Daily 3X Leverage.
Given just how high that expenditure is. The Company is focused on developing transformative therapies for central nervous system CNS. Passage Bio Incs market cap currently stands at around 16811 million with investors looking forward to this quarters earnings report slated for Mar 01 2022 Mar 07.
25700 52 Week Range 198400. New target price is 372 above last closing price of US495. 8901K 65 Day Avg.
Get the latest Passage Bio PASG detailed stock quotes stock data Real-Time ECN charts stats and more. Please note that any opinions estimates or. View Passage Bio PASG investment stock information.
Find the latest Passage Bio Inc. The average PASSAGE BIO stock price prediction forecasts a potential upside of. 29100 Day Range 31100.
1D 5D 1M 3M 6M YTD 1Y 3Y All Range Dropdown. 10 2022 GLOBE NEWSWIRE -- Passage Bio Inc. Learn More About Our Differentiated RD Strategy.
On average Wall Street analysts predict. Stock Price Forecast The 7 analysts offering 12-month price forecasts for Passage Bio Inc have a median target of 1600 with a high estimate of 3400 and a low estimate of 400. 6 equities research analysts have issued 1-year target prices for Passage Bios shares.
That PASSAGE BIOs share price could reach 1833 by Mar 8 2023. Is followed by the analysts listed above. Since it has a market capitalisation of US106m Passage Bios US153m in cash burn equates to about 143 of its market value.
PASG Passage Bio Inc. Earnings for Passage Bio are expected to grow in the coming year from 347 to 241 per share.
Pasg Stock Price And Chart Nasdaq Pasg Tradingview
Pasg Stock Price And Chart Nasdaq Pasg Tradingview
Institutional Investors May Adopt Severe Steps After Passage Bio Inc S Nasdaq Pasg Latest 13 Drop Adds To A Year Losses Simply Wall St News
What Type Of Shareholders Make Up Passage Bio Inc S Nasdaq Pasg Share Registry
Passage Bio Inc Share Price Usd0 0001
0ppx8rz1 5 V6m
Passage Bio Stock Pasg Price Reduced But Without Data Does Not Look Convincing Seeking Alpha
Passage Bio Inc Investors And News Stock Information
Bluebird Bio Biomarin Tabbed As Top Acquisition Targets
Passage Bio Inc Investors And News Stock Information
Passage Bio Inc Shares Near 52 Week Low Market Mover Nasdaq
Passage Bio Stock Forecast Price News Nasdaq Pasg
Passage Bio Inc Common Stock Pasg Stock Price Quote News History Nasdaq
Pasg Stock Price And Chart Nasdaq Pasg Tradingview
Passage Bio To Cut Workforce Prioritize R D Programs To Reduce Operating Expenses
Pasg Stock Price And Chart Nasdaq Pasg Tradingview
Passage Bio Stock Pasg Price Reduced But Without Data Does Not Look Convincing Seeking Alpha
Stocks That Hit 52 Week Lows On Monday Benzinga
0ofjfci 1 Shpm
